Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.010
+0.080 (2.73%)
At close: Jan 31, 2025, 4:00 PM
3.020
+0.010 (0.33%)
After-hours: Jan 31, 2025, 4:57 PM EST
Mereo BioPharma Group Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for MREO stock have an average target of 7.83, with a low estimate of 7.00 and a high estimate of 10. The average target predicts an increase of 160.13% from the current stock price of 3.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MREO stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Jan 13, 2025 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $10 | Buy | Initiates | $10 | +232.23% | Dec 24, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Dec 17, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +132.56% | Dec 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +132.56% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
8.31M
from 10.00M
Decreased by -16.86%
Revenue Next Year
12.84M
from 8.31M
Increased by 54.47%
EPS This Year
-0.05
from -0.22
EPS Next Year
-0.17
from -0.05
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 59.9M | 36.8M | 63.8M | |||
| Avg | 8.3M | 12.8M | 36.8M | |||
| Low | n/a | n/a | 1.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 499.1% | 342.3% | 397.0% | |||
| Avg | -16.9% | 54.5% | 186.4% | |||
| Low | - | - | -92.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.04 | 0.09 | - | |||
| Avg | -0.05 | -0.17 | -0.03 | |||
| Low | -0.05 | -0.76 | -0.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.